These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19842101)

  • 21. Improvement in quality of life after radiofrequency ablation.
    Hlatky MA; Wang P
    Pacing Clin Electrophysiol; 2006 Apr; 29(4):341-2. PubMed ID: 16650259
    [No Abstract]   [Full Text] [Related]  

  • 22. [ The ABC's of medical statistics. Reading and understanding clinical trials ].
    Labenz J; Kunz CU
    Radiologe; 2011 Jan; 51(1):65-75; quiz 76. PubMed ID: 21243463
    [No Abstract]   [Full Text] [Related]  

  • 23. [Composite endpoints in clinical trials].
    Ferreira-González I; Alonso-Coello P; Solà I; Pacheco-Huergo V; Domingo-Salvany A; Alonso J; Montori V; Permanyer-Miralda G
    Rev Esp Cardiol; 2008 Mar; 61(3):283-90. PubMed ID: 18361902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How many repeated measurements are useful?
    Overall JE
    J Clin Psychol; 1996 May; 52(3):243-52. PubMed ID: 8835686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating patient-based outcome measures for use in clinical trials.
    Fitzpatrick R; Davey C; Buxton MJ; Jones DR
    Health Technol Assess; 1998; 2(14):i-iv, 1-74. PubMed ID: 9812244
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trials and the response rate illusion.
    Kirsch I; Moncrieff J
    Contemp Clin Trials; 2007 Jul; 28(4):348-51. PubMed ID: 17182286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and strategies for reevaluating the ACR20.
    Felson DT; Furst DE; Boers M
    J Rheumatol; 2007 May; 34(5):1184-7. PubMed ID: 17477484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
    Dobkin BH; Landau WM; Sahrmann S; Thomas Thach W; Simpson DM; Gracies JM; Graham K; Hallett M; Miyasaki J; Naumann M; Russman B; Simpson L; So Y
    Neurology; 2009 Sep; 73(9):736; author reply 737-8. PubMed ID: 19720984
    [No Abstract]   [Full Text] [Related]  

  • 29. Bounds on causal effects in randomized trials with noncompliance under monotonicity assumptions about covariates.
    Chiba Y
    Stat Med; 2009 Nov; 28(26):3249-59. PubMed ID: 19777494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An efficient test for the analysis of dichotomized variables when the reliability is known.
    Borm GF; Munneke M; Lemmers O; van Zuijlen M
    Stat Med; 2007 Aug; 26(18):3498-510. PubMed ID: 16981185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determining the most appropriate components for a composite clinical trial outcome.
    Bethel MA; Holman R; Haffner SM; Califf RM; Huntsman-Labed A; Hua TA; McMurray J
    Am Heart J; 2008 Oct; 156(4):633-40. PubMed ID: 18926145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction.
    Tugwell P; Boers M
    J Rheumatol; 1993 Mar; 20(3):528-30. PubMed ID: 8478864
    [No Abstract]   [Full Text] [Related]  

  • 33. Outcome measurement in osteoarthritis clinical trials.
    Bellamy N
    J Rheumatol Suppl; 1995 Feb; 43():49-51. PubMed ID: 7752137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome measures in rheumatoid arthritis clinical trials: assessing improvement.
    Kirwan JR
    J Rheumatol; 1993 Mar; 20(3):543-5. PubMed ID: 8478868
    [No Abstract]   [Full Text] [Related]  

  • 35. A review of the limitations of statistical analysis of treatment outcomes used in periodontal research.
    Galgut PN
    J Int Acad Periodontol; 2003 Oct; 5(4):92-7. PubMed ID: 14604057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoarthritis clinical trials: candidate variables and clinimetric properties.
    Bellamy N
    J Rheumatol; 1997 Apr; 24(4):768-78. PubMed ID: 9101516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methodology for clinical trials in rheumatology: logical foundations.
    Cook RJ; Farewell VT; Gladman DD
    J Rheumatol; 1997 Oct; 24(10):1861-5. PubMed ID: 9330922
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of state of the art statistical methodology in biomedical research: the example of methodology for interim analyses in clinical trials].
    Muñoz SR; Bangdiwala SI
    Rev Med Chil; 2001 Sep; 129(9):983-8. PubMed ID: 11725478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hierarchy of outcome assessment.
    Fries JF
    J Rheumatol; 1993 Mar; 20(3):546-7. PubMed ID: 8478869
    [No Abstract]   [Full Text] [Related]  

  • 40. Defining multiple sclerosis treatment response with magnetic resonance imaging: how much activity is too much?
    Giacomini PS; Arnold DL; Bar-Or A; Antel JP
    Arch Neurol; 2009 Jan; 66(1):19-20. PubMed ID: 19139295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.